Geode Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-330,898
| Closed | -$46.3M | – | 4194 |
|
|
2018
Q4 | $46.3M | Buy |
330,898
+15,413
| +5% | +$2.34M | 0.01% | 770 |
|
|
2018
Q3 | $53.9M | Buy |
315,485
+65,844
| +26% | +$11.1M | 0.02% | 765 |
|
|
2018
Q2 | $43.3M | Buy |
249,641
+35,529
| +17% | +$5.34M | 0.01% | 845 |
|
|
2018
Q1 | $24.7M | Buy |
214,112
+9,030
| +4% | +$960K | 0.01% | 1110 |
|
|
2017
Q4 | $17.3M | Sell |
205,082
-12,144
| -6% | -$1.01M | 0.01% | 1364 |
|
|
2017
Q3 | $20M | Buy |
217,226
+37,372
| +21% | +$2.9M | 0.01% | 1237 |
|
|
2017
Q2 | $14.4M | Buy |
179,854
+43,578
| +32% | +$2.41M | 0.01% | 1436 |
|
|
2017
Q1 | $5.73M | Buy |
136,276
+44,193
| +48% | +$1.82M | ﹤0.01% | 2009 |
|
|
2016
Q4 | $2.96M | Sell |
92,083
-8,697
| -9% | -$223K | ﹤0.01% | 2404 |
|
|
2016
Q3 | $2.64M | Buy |
100,780
+3,487
| +4% | +$91.2K | ﹤0.01% | 2389 |
|
|
2016
Q2 | $2.25M | Buy |
97,293
+40,225
| +70% | +$1M | ﹤0.01% | 2401 |
|
|
2016
Q1 | $1.56K | Buy |
57,068
+2,126
| +4% | +$44.5K | ﹤0.01% | 2609 |
|
|
2015
Q4 | $1.56M | Buy |
54,942
+10,700
| +24% | +$287K | ﹤0.01% | 2627 |
|
|
2015
Q3 | $773K | Buy |
44,242
+10,582
| +31% | +$207K | ﹤0.01% | 3022 |
|
|
2015
Q2 | $606K | Buy |
33,660
+4,868
| +17% | +$66.5K | ﹤0.01% | 3122 |
|
|
2015
Q1 | $358K | Buy |
28,792
+997
| +4% | +$12.4K | ﹤0.01% | 3334 |
|
|
2014
Q4 | $326K | Buy |
+27,795
| New | +$324K | ﹤0.01% | 3381 |
|
Other funds holding LOXO
Geode Capital Management's LOXO Position: Q1 2019 in Review
Geode Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 330,898 shares — an estimated $46.3M sold.
Geode Capital Management first reported a position in LOXO in Q4 2014 and held it in 17 quarters. The position peaked at $53.9M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Geode Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Geode Capital Management sold 330,898 Loxo Oncology, Inc shares in Q1 2019, an estimated $46.3M.
- Geode Capital Management first reported a position in Loxo Oncology, Inc in Q4 2014 and held it in 17 quarters.
- Geode Capital Management's Loxo Oncology, Inc position peaked at $53.9M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Geode Capital Management's 13F filing for Q1 2019, filed 14 May 2019.